Anti-TP53INP1 antibody
1
(1 Review)
|
(8 Publications)
Rabbit Polyclonal TP53INP1 antibody. Suitable for WB, IHC-P and reacts with Human samples. Cited in 8 publications. Immunogen corresponding to Synthetic Peptide within Human TP53INP1 aa 1-50.
View Alternative Names
P53DINP1, SIP, TP53INP1, Tumor protein p53-inducible nuclear protein 1, Stress-induced protein, p53-dependent damage-inducible nuclear protein 1, p53DINP1
- IHC-P
Unknown
Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-TP53INP1 antibody (AB9775)
Immunohistochemistry (Formalin-fixed paraffin embedded sections) of human liver tissue labelingp53 DINP1/TP53INP1 with Anti-p53 DINP1/TP53INP1 antibody (ab9775) at 5μg/ml.
- WB
Unknown
Western blot - Anti-TP53INP1 antibody (AB9775)
Western blot analysis of p53DINP1 expression in human lung tissue lysate with anti-p53DINP1 (ab9775) at 2 μg/ml in the absence (lane 1) or presence (lane 2) of blocking peptide (ab9776). Western blot analysis of p53DINP1 expression in human lung tissue lysate with anti-p53DINP1 (ab9775) at 2 µg/ml in the absence (lane 1) or presence (lane 2) of blocking peptide (ab9776).
All lanes:
Western blot - Anti-TP53INP1 antibody (ab9775)
false
- WB
CiteAb
Western blot - Anti-TP53INP1 antibody (AB9775)
TP53INP1 western blot using anti-TP53INP1 antibody ab9775. Publication image and figure legend from Jiang, F., Liu, T., et al., 2011, BMC Cancer, PubMed 21970405.
ab9775 was used in this publication in western blot. This may not be the same as the application(s) guaranteed by Abcam. For a full list of applications guaranteed by Abcam for ab9775 please see the product overview.
MiR-125b negatively regulated TP53INP1 protein levels in EC cells. A. Putative binding sites of miR-125b in the TP53INP1 3'UTR (white sequences) predicted by TargetScan. B. TP53INP1 protein levels were measured in EC cells at 72 h post-transfection by western blot assays. C. Potential binding site of miR-125b on TP53INP1 3'UTR in different species. The seed sequence is underlined. D. Sketch of the construction of pMIR-TP53INP1-3'UTR-WT or pMIR-TP53INP1-3'UTR-MT vectors. The mutant binding site is underlined and italicized. E. MiR-125bm down-regulated luciferase activities controlled by wild-type TP53INP1 3'UTR, but did not affect luciferase activity controlled by mutant TP53INP1 3'UTR (white sequences were mutated). The results are means of three independent experiments ± SD. (**P < 0.01 vs. blank; #P > 0.05 vs. blank).
false
Reactivity data
Properties and storage information
Form
Purification technique
Storage buffer
Shipped at conditions
Appropriate short-term storage conditions
Appropriate long-term storage conditions
Product protocols
- Visit the General protocols
- Visit the Troubleshooting
Target data
Publications (8)
Recent publications for all applications. Explore the full list and refine your search
Experimental eye research 199:108185 PubMed32841649
2020
Applications
Unspecified application
Species
Unspecified reactive species
Experimental cell research 383:111543 PubMed31374207
2019
Applications
Unspecified application
Species
Unspecified reactive species
Molecular medicine reports 11:1200-6 PubMed25369914
2014
Applications
Unspecified application
Species
Unspecified reactive species
International journal of clinical and experimental 7:602-10 PubMed24551280
2014
Applications
WB, IHC-P
Species
Human, Human
Investigative ophthalmology & visual science 54:3806-14 PubMed23661372
2013
Applications
Unspecified application
Species
Unspecified reactive species
Nucleic acids research 41:2239-54 PubMed23303785
2013
Applications
WB
Species
Unspecified reactive species
BMC cancer 11:425 PubMed21970405
2011
Applications
WB
Species
Human
Human molecular genetics 21:196-207 PubMed21965303
2011
Applications
WB
Species
Rat
Product promise
Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.
For licensing inquiries, please contact partnerships@abcam.com